BeStock  

Teleflex TFX

US equityMarket cap rank #1798Medical Instruments & Supplies
$161.58 −$1.82 (-1.11%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $161.58 0.00%
Open$164.07
Prev close$163.40
Day range$161.35 – $166.52
Volume655.0K
Market cap$6.41B
P/E (TTM)21.3
Dividend yield0.84%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$567.78M+0.1% YoY
Operating profit$105.08M+160.1% YoY
Net profit$927.43M+326.8% YoY
Diluted EPS$22.28+341.1% YoY
Free cash flow$126.15M+43.1% YoY
Operating cash flow$147.76M

Revenue, last 8 quarters

$-552.4MDec '24$414.3MMar '25$442.5MJun '25$566.9MSep '25$569.0MDec '25$548.3MMar '26$570.3MJun '26$567.8MSep '26

Net profit, last 8 quarters

$-136.7MDec '24$95.0MMar '25$122.6MJun '25$-408.9MSep '25$-714.3MDec '25$-8.2MMar '26$99.7MJun '26$927.4MSep '26

Diluted EPS by quarter

-2.95Dec '242.07Mar '252.77Jun '25-9.24Sep '25-16.15Dec '25-0.18Mar '262.28Jun '2622.28Sep '26

Free cash flow by quarter

$206.4MDec '24$49.0MMar '25$-20.0MJun '25$88.1MSep '25$128.4MDec '25$30.2MMar '26$80.3MJun '26$126.1MSep '26

Annual revenue

$2.5BFY20$2.8BFY21$2.8BFY22$1.7BFY23$1.7BFY24$2.0BFY25

Profitability & balance sheet

Gross margin58.3%
Operating margin11.2%
Net margin13.5%
Return on equity8.3%
Return on assets4.3%
Return on invested capital6.5%
Current ratio2.01
Liabilities / assets45.0%
Cash & investments$430.47M
Total debt$1.68B
Net cash (debt)-$1.25B
Free cash flow / sales16.2%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Vascular$243.45M 42.9%
  • Interventional$210.30M 37.0%
  • Surgical$114.03M 20.1%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $567.78M $570.33M $548.26M $1.99B $568.98M
Total Operating Revenue $567.78M $570.33M $548.26M $1.99B $568.98M
Cost of Revenue $199.00M $238.63M $240.84M $871.96M $261.54M
Gross Profit $368.79M $331.71M $307.43M $1.12B $307.45M
Operating Expense $263.71M $258.64M $270.40M $864.95M $271.11M
Selling and Admin Expenses $220.72M $213.52M $226.01M $720.17M $222.37M
Research & Development $42.98M $45.12M $44.39M $144.78M $48.74M
Operating Profit $105.08M $73.07M $37.03M $255.80M $36.34M
Net Non-Operating Interest Income (Expense) -$18.92M -$26.54M -$24.01M -$93.82M -$26.30M
Non-Operating Interest Income $2.28M $1.42M $1.71M $6.40M $1.85M
Non-Operating Interest Expense $21.21M $27.95M $25.72M $100.22M $28.15M
Other Income (Expense) -$3.04M -$1.40M -$16.85M -$137.43M -$22.47M
Special Income (Charges) -$3.04M -$1.40M -$16.85M -$137.43M -$22.47M
-Less:Restructuring and Mergern & Acquisition -$346,000.00 $246,000.00 -$224,000.00 $29.31M $22.47M
-Less:Other Special Charges $3.38M $1.15M – – –
Pretax Profit $83.12M $45.14M -$3.83M $24.55M -$12.42M
Tax $28.84M $3.38M $1.01M -$33.98M -$8.87M
Net Profit $927.43M $99.69M -$8.15M -$905.64M -$714.33M
Profit from Continuing Operations $54.29M $41.76M -$4.84M $58.53M -$3.55M
Net Income from Discontinuous Operations $873.14M $57.93M -$3.32M -$964.17M -$710.78M
Net Income to Parent Company $927.43M $99.69M -$8.15M -$905.64M -$714.33M
Net Income to Common Stockholders $927.43M $99.69M -$8.15M -$905.64M -$714.33M
Basic EPS $22.36 $2.29 -$0.18 -$20.30 -$16.15
Diluted EPS $22.28 $2.28 -$0.18 -$20.30 -$16.15
Dividend Per Share $0.34 $0.34 $0.34 $1.36 $0.34
-Gain on Sale Of Business – – -$17.07M – –
-Less:Write Off – – – $108.12M –
-Gain on Sale of Property/Plant/Equipment – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $6.35B $6.79B $6.78B $6.95B $6.95B
Total Current Assets $1.84B $1.88B $1.86B $1.94B $1.94B
Cash and Cash Equivalents & Short-Term Investments $430.47M $300.16M $309.41M $378.56M $378.56M
-Cash and Cash Equivalents $430.47M $300.16M $309.41M $378.56M $378.56M
Receivables $379.64M $364.61M $365.53M $345.58M $345.58M
-Accounts Receivable $379.64M $364.61M $365.53M $345.58M $345.58M
Prepaid Assets $7.08M $36.46M $16.79M $19.57M $19.57M
Inventory $384.42M $351.91M $380.86M $404.40M $404.40M
Other Current Assets $163.48M $148.22M $149.81M $150.68M $150.68M
Total Non-Current Assets $4.50B $4.91B $4.92B $5.01B $5.01B
Net PPE $544.04M $552.80M $561.87M $590.10M $590.10M
-Gross PPE $544.04M $552.80M $561.87M $1.06B $1.06B
Goodwill and Other Intangible Assets $3.69B $3.74B $3.78B $3.83B $3.83B
-Goodwill $2.29B $2.29B $2.30B $2.31B $2.31B
-Other Intangible Assets $1.40B $1.45B $1.49B $1.52B $1.52B
Non-Current Deferred Assets $12.77M $12.64M $12.21M $12.59M $12.59M
Other Non-Current Assets $253.30M $604.36M $565.93M $577.01M $577.01M
Total Liabilities $2.85B $3.88B $3.70B $3.82B $3.82B
Total Current Liabilities $917.10M $720.38M $728.05M $762.03M $762.03M
Payables $337.51M $161.08M $155.45M $148.99M $148.99M
-Accounts Payable $142.87M $143.29M $143.63M $130.20M $130.20M
-Total Tax Payable $194.64M $17.79M $11.82M $18.79M $18.79M
Current Accrued Expenses $292.30M $247.94M $238.25M $247.52M $247.52M
Short-Term Debt and Capital Lease Obligation $87.50M $87.50M $103.13M $100.00M $100.00M
-Current Debt $87.50M $87.50M $103.13M $100.00M $100.00M
Other Current Liabilities $199.79M $223.86M $231.23M $265.52M $265.52M
Total Non-Current Liabilities $1.94B $3.16B $2.97B $3.06B $3.06B
Long Term Accounts Payable and Other Payables $3.68M $3.80M $3.83M $3.54M $3.54M
Long Term Debt and Capital Lease Obligation $1.59B $2.79B $2.58B $2.63B $2.63B
-Long Term Debt $1.53B $2.72B $2.51B $2.54B $2.54B
-Long Term Capital Lease Obligation $60.79M $64.54M $68.32M $84.21M $84.21M
Non-Current Deferred Liabilities $168.57M $146.14M $169.43M $183.75M $183.75M
Other Non-Current Liabilities $161.16M $174.90M $162.51M $194.53M $194.53M
Total Equity $3.49B $2.90B $3.08B $3.12B $3.12B
Stockholders' Equity $3.49B $2.90B $3.08B $3.12B $3.12B
Capital Stock $48.20M $48.20M $48.20M $48.20M $48.20M
-Common Stock $48.20M $48.20M $48.20M $48.20M $48.20M
Additional Paid-In Capital $765.45M $808.74M $805.32M $815.81M $815.81M
Retained Earnings $4.12B $3.21B $3.13B $3.15B $3.15B
Less: Treasury Stock -$1.15B -$886.76M -$636.64M -$649.53M -$649.53M
Gains/Losses Not Affecting Retained Earnings -$297.00M -$276.98M -$258.94M -$239.47M -$239.47M
-Accumulated Depreciation – – – -$470.06M -$470.06M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $147.76M $94.33M $49.02M $340.68M $152.21M
Net cash flow from continuing operations $96.28M $91.90M $46.66M $96.68M $86.41M
Net Income from Continuing Operations $927.43M $99.69M -$8.15M -$905.64M -$714.33M
Gain/Loss from Continuing Operations $3.38M – – -$82.64M $0.00
Depreciation & Depletion & Amortization $51.58M $49.82M $53.74M $177.74M $53.58M
Deferred Tax $17.25M -$3.38M -$12.71M -$100.97M -$63.43M
Other Non-Cash Items -$883.23M -$64.04M -$2.58M $955.46M $701.03M
Change in Working Capital -$26.41M $3.21M $9.62M -$45.36M $138.60M
-Change in Receivables -$17.08M $1.37M -$25.01M -$85.53M $9.40M
-Change in Inventory -$34.09M $27.78M $16.47M $84.04M $31.21M
-Change in Prepaid Assets -$17.07M $9.46M $3.43M -$35.59M -$11.34M
-Change in Payables and Accrued Expense $41.48M -$14.25M $8.20M -$8.28M $16.05M
-Change In Other Working Capital $355,000.00 -$21.14M $6.53M – –
Cash Flow from Discontinued Operating Activities $51.48M $2.43M $2.36M $244.00M $65.80M
Net cash flow from investing $1.48B -$15.51M -$84.00M -$849.19M -$22.41M
Net Cash Flow from Continuing Investing Activities -$20.36M -$6.58M -$74.79M -$812.65M -$10.35M
Capital Expenditure -$21.61M -$14.03M -$18.79M -$95.24M -$23.82M
Net Business Purchase and Sale $0.00 $0.00 $0.00 -$825.15M $0.00
Net Investment Purchase and Sale $1.25M $7.45M -$55.99M -$5.00M -$7.61M
Financing Cash Flow -$1.51B -$82.00M -$44.99M $611.54M -$61.61M
Net Cash Flow from Continuing Financing Activities -$1.51B -$82.00M -$44.99M $611.54M -$61.61M
Net Issuance Payments Of Debt -$1.20B $186.27M -$25.25M $987.00M -$26.29M
Net Common Stock Issuance -$304.95M -$250.00M $0.00 -$300.00M $0.00
Cash Dividends Paid -$13.92M -$14.78M -$15.05M -$60.27M -$15.03M
Proceeds from Stock Option Exercised -$118,000.00 -$638,000.00 -$4.63M $7.17M $6,000.00
Net Other Financing Charges -$49,000.00 -$2.85M -$58,000.00 -$22.36M -$20.30M
Ending Cash Balance $444.33M $316.92M $329.55M $402.68M $402.68M
Net Change in Cash $113.84M -$3.18M -$79.96M $103.03M $68.19M
Beginning Cash Balance $316.92M $329.55M $453.85M $327.65M $336.51M
Effect of Exchange Rate Changes -$616,000.00 -$1.53M -$4.89M $23.17M $4.35M
Free Cash Flow $126.15M $80.30M $30.23M $245.44M $128.39M
Net Other Investing Changes – – – $91.65M $0.00

Discussion

No comments yet — be the first to weigh in on TFX.

Sign in to join the discussion.

Scroll to Top